The Biden administration is looking to extend Medicare and Medicaid coverage to include obesity drugs like Wegovy and Zepbound. Weight loss drugs are now excluded from mandatory coverage.
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...
President Joe Biden has proposed expanding Medicare and Medicaid coverage for anti-obesity drugs to over 7 million Americans.
Shares of weight-loss drugmakers Novo Nordisk and Eli Lilly rose on Tuesday after U.S. President Joe Biden proposed expanding ...
If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs ...
The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.
The new rule, which was proposed by the administration on Tuesday, would dramatically expand access to anti-obesity ...
CMS proposes changes to Medicare and Medicaid to cover weight-loss drugs, recognizing obesity as a disease. This could expand ...
The Biden administration’s latest proposal to allow Medicare and Medicaid to cover weight loss drugs such as Ozempic and ...
The plans from the Department of Health and Human Services come on the heels of criticism Ozempic and other weight loss medications received by RFK Jr.
Proposal would let patients get Wegovy, Ozempic, related drugs for obesity, which is not a covered condition now.
Biden administration's proposal to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback